Rigel Pharmaceuticals RIGL
$40.09 −$1.10 (-2.67%)
Market closed · Nov 21, 9:10 am ET · Last extended-hours $40.00 -0.22%
Open$40.65
Prev close$41.19
Day range$39.62 – $41.66
Volume352.2K
Market cap$754.89M
P/E (TTM)2.5
Dividend yield–
RIGL Stock News
Headlines matching Rigel Pharmaceuticals or the RIGL ticker, most recent first.
- Citi Maintains Rigel Pharmaceuticals(RIGL.US) With Buy Rating, Raises Target Price to $83 Positive
- Citi Maintains Rigel Pharmaceuticals(RIGL.US) With Buy Rating, Maintains Target Price $83
- H.C. Wainwright Maintains Rigel Pharmaceuticals(RIGL.US) With Buy Rating, Maintains Target Price $57
- Cantor Fitzgerald Maintains Rigel Pharmaceuticals(RIGL.US) With Hold Rating, Raises Target Price to $43 Positive
- Piper Sandler Maintains Rigel Pharmaceuticals(RIGL.US) With Hold Rating, Raises Target Price to $49 Positive
- H.C. Wainwright Maintains Rigel Pharmaceuticals(RIGL.US) With Buy Rating, Raises Target Price to $85 Positive
- Citi Maintains Rigel Pharmaceuticals(RIGL.US) With Buy Rating, Cuts Target Price to $69 Negative
- Citi Maintains Rigel Pharmaceuticals(RIGL.US) With Buy Rating, Maintains Target Price $81
- Citi Maintains Rigel Pharmaceuticals(RIGL.US) With Buy Rating, Raises Target Price to $81 Positive
- Piper Sandler Maintains Rigel Pharmaceuticals(RIGL.US) With Hold Rating, Maintains Target Price $40
- Piper Sandler Maintains Rigel Pharmaceuticals(RIGL.US) With Hold Rating, Cuts Target Price to $40 Negative
- Citi Maintains Rigel Pharmaceuticals(RIGL.US) With Buy Rating, Maintains Target Price $71
- Cantor Fitzgerald Maintains Rigel Pharmaceuticals(RIGL.US) With Hold Rating, Maintains Target Price $38
- Piper Sandler Maintains Rigel Pharmaceuticals(RIGL.US) With Hold Rating, Raises Target Price to $42 Positive
- Citi Maintains Rigel Pharmaceuticals(RIGL.US) With Buy Rating, Maintains Target Price $86
No comments yet — be the first to weigh in on RIGL.
Sign in to join the discussion.